enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. PerkinElmer to pay $5.25B for antibody maker BioLegend

    www.aol.com/news/perkinelmer-pay-5-25b-antibody...

    PerkinElmer will spend about $5.25 billion to acquire BioLegend, which makes antibodies used in gene therapy and reagents for drug discovery. The Waltham, Massachusetts, company said Monday that ...

  3. BioLegend - Wikipedia

    en.wikipedia.org/wiki/BioLegend

    BioLegend is a global developer and manufacturer of antibodies and reagents used in biomedical research located in San Diego, California. [1] It was incorporated in June 2002 and has since expanded to include BioLegend Japan KK, where it is partnered with Tomy Digital Biology Co., Ltd. in Tokyo, BioLegend Europe in the United Kingdom, BioLegend GmbH in Germany, and BioLegend UK Ltd in the ...

  4. PerkinElmer to buy antibodies maker BioLegend for about $5.3 ...

    www.aol.com/news/perkinelmer-buy-antibodies...

    For premium support please call: 800-290-4726 more ways to reach us

  5. PerkinElmer (PKI) to Benefit From BioLegend Buyout: Here's How

    www.aol.com/news/perkinelmer-pki-benefit...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Revvity - Wikipedia

    en.wikipedia.org/wiki/Revvity

    Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, [1] especially in relation to approaches making use of new cell therapy or gene therapy developments. [2]

  7. AOL latest headlines, entertainment, sports, articles for business, health and world news.

  8. Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL

  9. PerkinElmer - Wikipedia

    en.wikipedia.org/wiki/PerkinElmer

    PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation that was founded in 1937 and originally focused on precision optics.Over the years it went into and out of several different businesses via acquisitions and divestitures; these included defense products, semiconductors, computer systems, and others.